Dissemin is shutting down on January 1st, 2025

Published in

Springer, Journal of Clinical Immunology, 4(41), p. 769-779, 2021

DOI: 10.1007/s10875-020-00943-y

Links

Tools

Export citation

Search in Google Scholar

Stepwise Reversal of Immune Dysregulation Due to STAT1 Gain-of-Function Mutation Following Ruxolitinib Bridge Therapy and Transplantation

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO